PHC Corporation赢得了2024年LicellMo分析师创新奖,促进细胞研究。 PHC Corporation wins 2024 Innovation Award for its LiCellMo analyzer, advancing cell research.

PHC公司生物医学司获得分析科学家为LicellMo分析器颁发的2024年创新奖。 PHC Corporation's Biomedical Division has been awarded the 2024 Innovation Award by The Analytical Scientist for its LiCellMo analyzer. 该设备提供关于细胞新陈代谢途径的连续数据,以前细胞状态随着时间推移而发生无法观察的变化,其目的是加强研究成果和治疗进展。 This device offers continuous data on cellular metabolic pathways, previously unobservable changes in cell states over time, and aims to enhance research findings and therapy advancements. 它提高了细胞和基因治疗发展的可复制性和质量。 It improves reproducibility and quality in cell and gene therapy development.